-
Mashup Score: 7Validate User - 11 day(s) ago
We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will take you to your
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 36Promising target for CAR T-cell therapy leads to potent antitumor responses against cutaneous and rare melanomas - 2 month(s) ago
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed …
Source: medicalxpress.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3
Nature – A study examines the effects of mutations that occur naturally in T cell cancers, reporting that such mutations can potentially be exploited to increase the potency of T cell therapies.
Source: www.nature.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 2
Nature – A study examines the effects of mutations that occur naturally in T cell cancers, reporting that such mutations can potentially be exploited to increase the potency of T cell therapies.
Source: www.nature.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 2
Nature – A study examines the effects of mutations that occur naturally in T cell cancers, reporting that such mutations can potentially be exploited to increase the potency of T cell therapies.
Source: www.nature.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 2
Nature – A study examines the effects of mutations that occur naturally in T cell cancers, reporting that such mutations can potentially be exploited to increase the potency of T cell therapies.
Source: www.nature.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 32Opinion | When a Revolutionary Cancer Treatment Causes Cancer - 3 month(s) ago
The potential benefits of CAR T-cell therapies still far outweigh the risks
Source: www.medpagetoday.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 31Opinion | When a Revolutionary Cancer Treatment Causes Cancer - 3 month(s) ago
The potential benefits of CAR T-cell therapies still far outweigh the risks
Source: www.medpagetoday.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3ASTCT, AACI, and ACCC Launch RECUR Initiative to Enhance Patient Access to CAR T Therapy - 3 month(s) ago
The American Society for Transplantation and Cellular Therapy (ASTCT), the Association of American Cancer Institutes (AACI), and the Association …
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet-
ASTCT, @AACI_Cancer & @ACCCBuzz recently launched the RECUR Initiative. This collaboration aims to revolutionize the evaluation process for #CART therapy by focusing on five crucial factors to ensure timely & personalized care. Read the full press release: https://t.co/QggbLeXD84 https://t.co/sbyk9tTRgP
-
-
Mashup Score: 44Cell therapy bigwigs endorse CAR-T in Nature Medicine article amid FDA safety probe - 3 month(s) ago
As an FDA investigation into patients developing secondary T-cell cancers
Source: www.fiercepharma.comCategories: General Medicine News, Hem/OncsTweet
RT @vandenBrinkLab: Our new study in @BloodJournal! Congrats to Brandon, @ScottJamesCART and co-authors! https://t.co/lmYDIRDaoB #CART #mye…